Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy

被引：0
|
作者：
Pei-Yu Huang
Ting-Ting Zeng
Xiaojiao Ban
Meng-Qing Li
Bao-Zhu Zhang
Ying-Hui Zhu
Wen-Feng Hua
Hai-Qiang Mai
Li Zhang
Xin-Yuan Guan
Yan Li
机构：
[1] Sun Yat-sen University Cancer Center,State Key Laboratory of Oncology in South China
[2] Collaborative Innovation Center of Cancer Medicine,Department of Nasopharyngeal Carcinoma
[3] Sun Yat-sen University Cancer Center,Department of Medical Oncology
[4] Sun Yat-sen University Cancer Center,Department of Clinical Oncology
[5] The University of Hong Kong,undefined
来源：
BMC Cancer | / 16卷
关键词：
Nasopharyngeal carcinoma; Gene amplification; EIF5A2; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Expression of EIF5A2 associates with poor survival of nasopharyngeal carcinoma patients treated with induction chemotherapy
    Huang, Pei-Yu
    Zeng, Ting-Ting
    Ban, Xiaojiao
    Li, Meng-Qing
    Zhang, Bao-Zhu
    Zhu, Ying-Hui
    Hua, Wen-Feng
    Mai, Hai-Qiang
    Zhang, Li
    Guan, Xin-Yuan
    Li, Yan
    BMC CANCER, 2016, 16
  • [2] Overexpression of EIF5A2 Predicts Poor Prognosis in Patients with Oral Squamous Cell Carcinoma
    Lin, Yueh-Min
    Chen, Mei-Ling
    Chen, Chia-Lo
    Yeh, Chung-Min
    Sung, Wen-Wei
    DIAGNOSTICS, 2020, 10 (07)
  • [3] Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer
    Zheng, Xin
    Gao, Lei
    Wang, Bo-tao
    Shen, Ping
    Yuan, Xiang-fei
    Zhang, Lan-Qiu
    Yang, Lei
    Zhang, Da-Peng
    Zhang, Qi
    Wang, Xi-Mo
    HISTOLOGY AND HISTOPATHOLOGY, 2020, 35 (06) : 579 - 587
  • [4] The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
    Liang Peng
    Jin-Qi Liu
    Cheng Xu
    Xiao-Dan Huang
    Ling-Long Tang
    Yu-Pei Chen
    Ying Sun
    Jun Ma
    Radiation Oncology, 14
  • [5] The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma
    Peng, Liang
    Liu, Jin-Qi
    Xu, Cheng
    Huang, Xiao-Dan
    Tang, Ling-Long
    Chen, Yu-Pei
    Sun, Ying
    Ma, Jun
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [6] Inherently poor survival of elderly patients with nasopharyngeal carcinoma
    Zhang, Ye
    Yi, Jun-Lin
    Huang, Xiao-Dong
    Xu, Guo-Zhen
    Xiao, Jian-Ping
    Li, Su-Yan
    Luo, Jing-Wei
    Zhang, Shi-Ping
    Wang, Kai
    Qu, Yuan
    Gao, Li
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (06): : 771 - 776
  • [7] The impact of the interval between the induction of chemotherapy and radiotherapy on the survival of patients with nasopharyngeal carcinoma
    Yang, Shiping
    Fu, Xiaoling
    Huang, Guang
    Chen, Junni
    Luo, Shishi
    Wang, Zhenping
    Kong, Fanzhong
    Wu, Gang
    Lin, Shaomin
    Wang, Fen
    Chen, Longhua
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 2313 - 2320
  • [8] Increased Angiogenin Expression Correlates With Radiation Resistance and Predicts Poor Survival for Patients With Nasopharyngeal Carcinoma
    Guo, Shan-Shan
    Liang, Yu-Jing
    Liu, Li-Ting
    Chen, Qiu-Yan
    Wen, Yue-Feng
    Liu, Sai-Lan
    Sun, Xue-Song
    Tang, Qing-Nan
    Li, Xiao-Yun
    Mai, Hai-Qiang
    Tang, Lin-Quan
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [9] Low expression of nm23-H1 associates with poor survival of nasopharyngeal carcinoma patients A prisma-compliant meta-analysis
    Yuan, Cheng
    Xu, Xin-Hua
    Xu, Lu
    Sun, Min
    Ni, Li-Hua
    Liu, Yang
    Ran, Feng
    Wang, Xiao-Long
    Chen, Zhuo
    Zhang, Kun
    Zeng, Guang
    MEDICINE, 2017, 96 (24)
  • [10] Overexpression of EIF5A2 in upper urinary tract urothelial carcinoma is a new independent prognostic marker of survival
    Fang, Yong
    Cen, Jun-Jie
    Cao, Jia-Zheng
    Huang, Yong
    Feng, Zi-Hao
    Lu, Jun
    Wei, Jin-Huan
    Chen, Zhen-Hua
    Liang, Yan-Ping
    Liao, Bing
    Luo, Jun-Hang
    Chen, Wei
    FUTURE ONCOLOGY, 2019, 15 (17) : 2009 - 2018
12345